Transcripta Bio
United States · $24.0M raised
- Total Funding
- $24.0M
- Last Round
- $24.0M Series AJul 2026
- Rounds
- 1
About
AI-powered drug discovery for neurological diseases
Summary
Transcripta Bio is an Artificial Intelligence company based in United States. It has raised $24.0M in total across 1 round, most recently a $24.0M Series A round in Jul 2026.
Funding History
Jul 2026
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Scientific superintelligence platform building autonomous AI labs for life, chemical, and materia...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.